Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide
In the 1950s the drug thalidomide administered as a sedative to pregnant women led to the birth of thousands of children with multiple defects. Despite its teratogenicity, thalidomide and its derivatives lenalidomide and pomalidomide (together known as Immunomodulatory Drugs: IMiDs) recently emerged...
Main Authors: | Fischer, Eric S., Böhm, Kerstin, Lydeard, John R., Yang, Haidi, Stadler, Michael B., Cavadini, Simone, Nagel, Jane, Serluca, Fabrizio, Acker, Vincent, Lingaraju, Gondichatnahalli M., Tichkule, Ritesh B., Schebesta, Michael, Forrester, William C., Schirle, Markus, Hassiepen, Ulrich, Ottl, Johannes, Hild, Marc, Beckwith, Rohan E. J., Harper, J. Wade, Jenkins, Jeremy L., Thomä, Nicolas H. |
---|---|
Format: | Online |
Language: | English |
Published: |
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423819/ |
Similar Items
-
Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy
by: Thakurta, A, et al.
Published: (2014) -
The deubiquitinating protein USP24 interacts with DDB2 and regulates DDB2 stability
by: Zhang, Ling, et al.
Published: (2012) -
Rethinking thalidomide.
Published: (1995) -
Genetic Interactions of Arabidopsis thaliana Damaged DNA Binding Protein 1B (DDB1B) With DDB1A, DET1, and COP1
by: Ganpudi, Ashwin L., et al.
Published: (2013) -
Thalidomide in Dermatology: Revisited
by: Hassan, Iffat, et al.
Published: (2015)